Naratriptan Hydrochloride

盐酸那拉曲坦

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameNaratriptan Hydrochloride
Drug Alias Name那拉曲坦naratriptanum那拉曲普坦AmergeNaramig +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor agonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcGlaxosmithkline Llc
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN02CC02
Related LinksWikipediaDrugBankKEGG